Basic Information
| Drug ID | DDPD04890 |
|
| Drug Name | Bepotastine | |
| Molecular Weight | 388.888 | |
| Molecular Formula | C21H25ClN2O3 | |
| CAS Number | 125602-71-3 | |
| SMILES | OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 | |
| External Links | ||
| DRUGBANK | DB04890 | |
| T3DB | T3D3066 | |
| PubChem Compound | 2350 | |
| PDR | 1212 | |
| Drugs.com | Drugs.com Drug Page | |
Experimental Physicochemical Property
Not Available
Pharmacokinetic/ Toxicokinetic Property
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Factor | Reference |
|---|---|---|---|---|---|---|---|
| C Max | 7.3 | ng/ml | 7.3±1.9 | ng/ml | DRUGBANK | ||
| T Max | 1.2 | h | 1.2 | h | DRUGBANK | ||
| Half-life | 2.5 | h | 2.5 | h | elimination half-life; | DRUGBANK | |
| Eliminate Route | 82.5 | % | 75-90 | % | Urinary excretion; PO, oral; Unchanged drug; | DRUGBANK | |
| Protein Binding | 55.4 | % | 55.4 | % | plasma proteins; PO, oral; | Plasma Concentration → ; | DRUGBANK |
Maximum Dosage
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
|---|---|---|---|---|---|---|---|---|
| Max dose for children | 2.0 | drop/day | 2 | drop/day | ophthalmic administration | Bepreve | bepotastine besilate | PDR |
| Max dose for adolescents | 2.0 | drop/day | 2 | drop/day | ophthalmic administration | Bepreve | bepotastine besilate | PDR |
| Max dose for adults | 2.0 | drop/day | 2 | drop/day | ophthalmic administration | Bepreve | bepotastine besilate | PDR |
| Max dose for elderly | 2.0 | drop/day | 2 | drop/day | ophthalmic administration | Bepreve | bepotastine besilate | PDR |
Drug Property Radar Chart
Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1